186 related articles for article (PubMed ID: 18644511)
1. Common obstacles in lipid management.
Elpers M
Crit Care Nurs Clin North Am; 2008 Sep; 20(3):287-95. PubMed ID: 18644511
[TBL] [Abstract][Full Text] [Related]
2. [Statines for all or individualized lipid lowering therapy?].
Parhofer K
MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
[No Abstract] [Full Text] [Related]
3. Drug treatment of lipid disorders.
Knopp RH
N Engl J Med; 1999 Aug; 341(7):498-511. PubMed ID: 10441607
[No Abstract] [Full Text] [Related]
4. Cardiovascular risk assessment and hyperlipidemia.
Becker J
Crit Care Nurs Clin North Am; 2008 Sep; 20(3):277-85. PubMed ID: 18644510
[TBL] [Abstract][Full Text] [Related]
5. Hyperlipidemia treatment in children: the younger, the better.
Gauer R
Am Fam Physician; 2010 Sep; 82(5):460. PubMed ID: 20822078
[No Abstract] [Full Text] [Related]
6. Novel approaches to the treatment of dyslipidemia.
Rader DJ
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):480-1. PubMed ID: 15731488
[No Abstract] [Full Text] [Related]
7. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
Hou R; Goldberg AC
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
[TBL] [Abstract][Full Text] [Related]
8. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
Montague T; Murphy B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
[TBL] [Abstract][Full Text] [Related]
9. Starting lipid lowering therapy in the hospital leads to longer-term use, study finds.
Rollins G
Rep Med Guidel Outcomes Res; 2004 Jan; 15(1):8-10. PubMed ID: 14994727
[No Abstract] [Full Text] [Related]
10. [Treatment of dyslipidemia in the secondary prevention of coronary artery disease].
Syvänne M
Duodecim; 1998; 114(15):1503-8. PubMed ID: 11552239
[No Abstract] [Full Text] [Related]
11. [Dyslipidemia is a risk for patients with kidney transplants. Do statins protect the kidney?].
MMW Fortschr Med; 2000 May; 142(21):69-70. PubMed ID: 10872303
[No Abstract] [Full Text] [Related]
12. [Lipid metabolism diseases].
Schwandt P
Med Monatsschr Pharm; 2003 Nov; 26(11):368-72; quiz 373-4. PubMed ID: 14652921
[No Abstract] [Full Text] [Related]
13. Lipid lowering therapy for adults with diabetes.
Jackowski L; Crockett J; Rowett D
Aust Fam Physician; 2008; 37(1-2):39-41. PubMed ID: 18239751
[TBL] [Abstract][Full Text] [Related]
14. Lipid management in the geriatric patient.
Nair AP; Darrow B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
[TBL] [Abstract][Full Text] [Related]
15. Common questions in managing hyperlipidemia.
Rosen IM; Sams RW
Prim Care; 2006 Dec; 33(4):903-21. PubMed ID: 17169673
[TBL] [Abstract][Full Text] [Related]
16. Re: Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
Yoshii Y; Ikeda K; Iwamoto K; Kawase Y; Iwasaki Y
Neurology; 2009 Mar; 72(10):944; author reply 944-5. PubMed ID: 19273834
[No Abstract] [Full Text] [Related]
17. The power of statins: aggressive lipid lowering.
Jones PH
Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
[TBL] [Abstract][Full Text] [Related]
18. The role of fibrates in a statin world.
Bloomfield HE
Arch Intern Med; 2006 Apr; 166(7):715-6. PubMed ID: 16606806
[No Abstract] [Full Text] [Related]
19. Lipid lowering, statins and cancer.
Wierzbicki AS
Int J Clin Pract; 2006 Sep; 60(9):1022-4. PubMed ID: 16939539
[No Abstract] [Full Text] [Related]
20. Diabetic maculopathy and lipid-lowering therapy.
Misra A; Vikram NK; Kumar A
Eye (Lond); 2004 Jan; 18(1):107-8. PubMed ID: 14707990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
